Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
bill maris
biofourmis
biotech
boston blog main
boston pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
casdin capital
chief executive officer
chronic kidney disease
clene nanomedicine
clinical trials
corvex management
covid-19
cystic fibrosis
detroit blog main
detroit top stories
digital therapeutics
dov goldstein
ed rebar
europe blog main
europe top stories
executive
gene therapy
gilead sciences
What
cancer
2
×
labor
2
×
abbvie’s
accuracy
ahead
bert
bio
biofourmis
biopsy
bucks
celebrate
chance
corner
day
days
detection
dr
earlier
forward
founders
fruits
holiday
hopkins
improve
johns
kenneth
kinzler
launches
liquid
looking
million
multiple
nickolas
papadopoulos
people
pharma
pitching
professors
rates
researchers
Language
unset
Current search:
labor
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@techcrunch.com
4 years ago
Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million
